Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04501913 · ClinicalTrials.gov registry record
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
A clinical trial of Clinical Stage II Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT04501913: Completed study of Clinical Stage II Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, sponsored by City of Hope Medical Center.
NCT04501913 is a study of Clinical Stage II Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 that has completed, run by City of Hope Medical Center. The registered enrollment target is 22 participants, below the 87-participant average among 10 other Clinical Stage II Esophageal Adenocarcinoma AJCC v8 trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04501913, a study of Clinical Stage II Esophageal Adenocarcinoma AJCC v8 and Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines at-home monitoring of patient-generated phsyiologic health data and patient-reported outcomes. Patient-generated health data using at-home monitoring devices and smart device applications are used more and more to measure value and quality in cancer care. This trial may show whether at-home monitoring programs can improve the care of patients after hospital discharge from surgery.
Primary Outcome
Planned accrual is bound by the number of eligibile patients and duration of the study funding. Accrual goal is 20 patients.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Patient Monitoring
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-12-24 |
| Est. Completion | 2025-10-17 |
What the finished NCT04501913 record still lists
NCT04501913 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 87-participant average among 10 other Clinical Stage II Esophageal Adenocarcinoma AJCC v8 trials with a reported enrollment target (75% lower).
The record links to 10 conditions, with Clinical Stage II Esophageal Adenocarcinoma AJCC v8 appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04501913 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04501913 about?
NCT04501913 is a clinical study titled "Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes". This study examines at-home monitoring of patient-generated phsyiologic health data and patient-reported outcomes. Patient-generated health data using at-home monitoring devices and smart device applications are used more and more to measure value and quality in cancer care. This trial may show whet...
What is the current status of trial NCT04501913?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2019-12-24. Estimated completion is 2025-10-17.
What conditions does trial NCT04501913 study?
This clinical trial studies the following conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage I Gastric Cancer AJCC v8.
What interventions are being tested in trial NCT04501913?
The interventions under investigation include: Questionnaire Administration (OTHER), Patient Monitoring (PROCEDURE).
Who is sponsoring clinical trial NCT04501913?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04501913 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clinical Stage II Esophageal Adenocarcinoma AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04501913's enrollment target sits among peer trials
22 10th of 10 higher than 1 of 10 other Clinical Stage II Esophageal Adenocarcinoma AJCC v8 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Clinical Stage II Esophageal Adenocarcinoma AJCC v8 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
RECRUITING · Phase 2
-
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
RECRUITING · Phase 2
-
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RECRUITING · Phase 2
-
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
RECRUITING · Phase 3
-
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
RECRUITING · Phase 1
-
Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI